Highlights in Early Breast Cancer From ASCO 2022 Highlights in Early Breast Cancer From ASCO 2022

Highlights in early breast cancer from ASCO 2022 include results from NeoSTAR in triple-negative disease and 8-year follow-up of the ASTRRA study in ER+/HER2- patients, as reported by Dr Ann Partridge.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news